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A novel synthetic chemistry approach to linkage-
speciﬁc ubiquitin conjugation†
Rachel E. Morgan, Vijay Chudasama, Paul Moody, Mark E. B. Smith and
Stephen Caddick*
Ubiquitination is of great importance as the post-translational
modiﬁcation of proteins with ubiquitin, or ubiquitin chains, facili-
tates a number of vital cellular processes. Herein we present a
facile method of preparing various ubiquitin conjugates under mild
conditions using michael acceptors based on dibromo-maleimides
and dibromo-pyridazinediones.
Ubiquitin is a small, highly conserved protein (∼8.5 kDa) that
is attached to target proteins through a post-translational
modification process known as ubiquitination. Ubiquitination
has a significant role in a number of cellular processes
1 and
the full extent of its importance is, as yet, not fully realised.
Methods that facilitate the study of ubiquitination have the
potential to significantly impact this fascinating and rapidly
expanding area of research.
2 In the process of ubiquitination,
ubiquitin can be added to the target protein singly or in the
form of chains. These linkages to and between ubiquitins
involves three enzymes: E1, E2 and E3. These enzymes gene-
rate an isopeptide link between the C-terminal glycine (G76) of
a ubiquitin and a lysine residue on a second ubiquitin or a
target protein. There are seven lysines residues on a ubiquitin
through which the isopeptide link can form: K6, K11, K27,
K29, K33, K48 and K63. The selectivity inherent in the require-
ment of three enzymes for ubiquitin conjugation, in particular
E3, makes accessing significant quantities of a range of
ubiquitinated proteins a major challenge. Synthetic eﬀorts
have sort to mimic the activity of these enzymes by conjugating
ubiquitins together using synthetic techniques.
3
When considering techniques to conjugate target proteins
to ubiquitin, ideally they should be easily accessible, mild and
require minimal steps. Otherwise the techniques would
preclude the modification of proteins of interest that are not
amenable to high temperatures or unusual buﬀer systems. We
sought to build upon the existing chemistry in our laboratory
to develop a novel, accessible and mild method of generating
ubiquitin conjugates.
4,5
We have recently shown dibromomaleimide 1 and dibromo-
pyridazinedione 2 (see Fig. 1) to be highly eﬀective moities for
the modification of proteins, through addition to cysteines,
under mild conditions. Conjugation of various chemical enti-
ties, such as thioglucose and glutathione, onto proteins has
been readily achieved.
4,5
Ubiquitin does not contain any cysteine residues, which
makes chemical modification of a ubiquitin cysteine mutant
via synthetic chemistry an attractive prospect. We envisaged a
method involving the coupling of two ubiquitin cysteine
mutants via a maleimide or pyridazinedione in place of the
isopeptide bond. This could be achieved by cysteine mutation
of a target lysine on one ubiquitin and a terminal glycine on
another ubiquitin (G76). Moreover, these cysteine mutants
could be expressed using standard expression systems, thus
allowing for all the advantages that this provides, such as cost,
time and scalability.
Therefore the following strategy was devised for the con-
struction of ubiquitin conjugates (see Fig. 2). Firstly, a lysine
to cysteine ubiquitin mutant, UbKXC 3, was to be reacted
with dibromomaleimide 1 or dibromopyridazinedione 2 to
form functionalised ubiquitin 5. Reaction of this species
with glycine to cysteine ubiquitin mutant UbG76C 6 should
then provide access to linkage-specific ubiquitin–ubiquitin
conjugate 7.
Fig. 1 Structures of selective cysteine modiﬁcation reagents: dibromo-
maleimide 1 and dibromopyridazinedione 2.
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View Article Online
View Journal | View IssueTo this end, we generated a range of ubiquitin cysteine
mutants: UbK27C, UbK48C, UbK63C and UbG76C. Of particu-
lar interest are ubiquitin conjugates attached through the K48
and K63 positions which have been indentified in a number of
biological processes.
6 Lysine 27 is noted as one of the most
challenging to modify using chemical techniques and would
therefore oﬀer a particular challenge to any new methodology.
7
Also, in order to examine the feasibility of using the approach
to aﬀect conjugation of ubiquitin onto a second protein, we
generated green fluorescent protein (GFP) mutant GFPS147C
8
which we could then use to generate ubiquitin-GFP
conjugates.
Ubiquitin mutants UbK27C, UbK48C and UbK63C (100 μL
and 1 mg mL
−1) were each incubated with 5 equivalents of
dibromomaleimide 1, on ice for 1 h. Consistent with our pre-
vious experience of protein modification with dibromomale-
imides (e.g. fast reaction time, exceptional thiol selectivity),
complete modification was observed.
4 In order to reduce the
potential for hydrolysis of the maleimide motif this modifi-
cation was carried out in sodium phosphate buﬀer at pH 6
(50 mM sodium phosphate pH 6, 75 mM NaCl). Incubation of
dibromomaleimide 1 with WT ubiquitin aﬀorded no reaction
after 24 h, indicating that the observed modifications had
occurred on the cystienes that had been introduced by site-
directed mutagenesis.
After removal of the excess dibromomaleimide from the
reaction mixture by ultrafiltration, UbG76C mutant 6 was
added to each of the samples. UbG76C was added in an equal
volume of sodium phosphate buﬀer at pH 8 (50 mM soduim
phosphate pH 8, 75 mM NaCl) in order to increase the rate of
coupling. Gratifyingly, for conjugates containing UbK48C and
UbK63C, coupling was complete after only 1 h on ice (Fig. 3).
Although a longer incubation period was required for UbK27C,
the product was observed after 24 h, this observation is con-
sistent with the diﬃculties reported in the literature and may
reflect the reduced accesibility of this residue.
7
We next set about evaluating the coupling of UbK48C and
UbG76C on a larger scale (600 μL at 1 mg mL
−1). This enabled
us to show that purification using size exclusion enables clean
Fig. 2 Overall strategy for the formation of ubiquitin conjugates. Struc-
ture modiﬁed from PDB ID: 1UBQ.
Fig. 3 Conjugation reactions for the formation of bis-protein conjugates 8–10. Structures modiﬁed from PDB ID: 1UBQ and 2B3P. Lanes in
SDS-PAGE gels are: 1-SeeBlue Plus2 ladder, 2-UbK48C, 3-coupling reaction, 4-GFPS147C. The band at ∼11 kDa in lane 3 is due to excess ubiquitin.
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View Article Onlineseparation of the coupled ubiquitin dimer from the uncoupled
ubiquitin and to obtain an excellent representative yield, 78%
(see ESI† for details).
Our coupling technique was next used to generate ubiqui-
tin-GFP conjugates. Both maleimide modified UbK48C and
UbG76C were incubated with GFPS147C. Conjugation was suc-
cessful for both conjugates and the coupling had no adverse
eﬀect on GFP fluorescence (see ESI† for details), thus indicat-
ing the potential for the use of this method to conjugate ubi-
quitin to a target protein.
We next evaluated dibromopyridazinedione 2 as a tool for
conjugation. The complete hydrolytic stability of this reagent
allowed for all the reactions to be performed at pH 8.
5
Although it should be mentioned that it is still possible to
carry out conjugation reactions at pH 6. Gratifyingly, using the
strategy outlined in Fig. 2 at pH 8, di-ubiquitin conjugates
UbK48C–UbG76C and UbK63C–UbG76C were generated.
Whilst modification of UbK27C with dibromopyridazinedione
was achievable, the reduced reactivity of the pyrid-
azinedione modified UbK27C precluded couping with
UbG76C under a reasonable time scale. However, to
our delight, ubiquitin-GFP conjugates using dibromopyrid-
azinedione 2 and UbK48C and UbG76C were successfully
isolated.
In conclusion we have presented a method of generating
ubiquitin-protein conjugates in a facile manner which is
achieved under mild conditions using short reaction
sequences. The use of this method to generate linkage-specific
ubiquitin–ubiquitin conjugates and ubiquitin-GFP conjugates
demonstrates the potential of this method to provide ready
access to a range of desired ubiquitin conjugates. In compari-
sion to other strategies,
3 this method allows the controlled,
linkage-specific coupling of ubiquitins, which can be
expressed in E. coli, and it does not require protecting groups
or the use of non-natural amino acids. We believe that this
methodology will be of use to researchers seeking to
delineate further the functional consequences of protein
ubiquitination.
We gratefully acknowledge UCL, EPSRC and Wellcome
Trust for funding. We would also like to thank Dr L. Cabrita
and Prof. J. Christodoulou for supplying the original ubiquitin
wt clone.
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